BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27910960)

  • 1. Unc-5 homolog B (UNC5B) is one of the key downstream targets of N-α-Acetyltransferase 10 (Naa10).
    Xu H; Han Y; Liu B; Li R
    Sci Rep; 2016 Dec; 6():38508. PubMed ID: 27910960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-α-acetyltransferase 10 (NAA10) in development: the role of NAA10.
    Lee MN; Kweon HY; Oh GT
    Exp Mol Med; 2018 Jul; 50(7):1-11. PubMed ID: 30054454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NAA10 as a New Prognostic Marker for Cancer Progression.
    Kim SM; Ha E; Kim J; Cho C; Shin SJ; Seo JH
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxylation of the Acetyltransferase NAA10 Trp38 Is Not an Enzyme-Switch in Human Cells.
    Ree R; Krogstad K; McTiernan N; Jakobsson ME; Arnesen T
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Lysine Acetyltransferase Activity of Recombinant Human ARD1/NAA10.
    Vo TTL; Park JH; Lee EJ; Nguyen YTK; Han BW; Nguyen HTT; Mun KC; Ha E; Kwon TK; Kim KW; Jeong CH; Seo JH
    Molecules; 2020 Jan; 25(3):. PubMed ID: 32013195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The N-terminal Acetyltransferase Naa10/ARD1 Does Not Acetylate Lysine Residues.
    Magin RS; March ZM; Marmorstein R
    J Biol Chem; 2016 Mar; 291(10):5270-7. PubMed ID: 26755727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The N-end rule pathway enzyme Naa10 supports epiblast specification in mouse embryonic stem cells by modulating FGF/MAPK.
    Takekoshi D; Tokuzawa Y; Sakanaka M; Kato H
    In Vitro Cell Dev Biol Anim; 2019 May; 55(5):355-367. PubMed ID: 30993557
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Kweon HY; Lee MN; Dorfel M; Seo S; Gottlieb L; PaPazyan T; McTiernan N; Ree R; Bolton D; Garcia A; Flory M; Crain J; Sebold A; Lyons S; Ismail A; Marchi E; Sonn SK; Jeong SJ; Jeon S; Ju S; Conway SJ; Kim T; Kim HS; Lee C; Roh TY; Arnesen T; Marmorstein R; Oh GT; Lyon GJ
    Elife; 2021 Aug; 10():. PubMed ID: 34355692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA-342-5p and miR-608 inhibit colon cancer tumorigenesis by targeting NAA10.
    Yang H; Li Q; Niu J; Li B; Jiang D; Wan Z; Yang Q; Jiang F; Wei P; Bai S
    Oncotarget; 2016 Jan; 7(3):2709-20. PubMed ID: 26646451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-α-Acetyltransferase 10 inhibits invasion and metastasis of oral squamous cell carcinoma via regulating Pirh2-p53 signalling pathway.
    Wang F; Zheng J; Yang J; Luo T; Xu J; Yang Y; Gu Y; Zeng Y
    J Cell Mol Med; 2022 May; 26(10):2921-2934. PubMed ID: 35366056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NAA10 promotes proliferation of renal cell carcinoma by upregulating UPK1B.
    Zhang ZY; Zhang JL; Zhao LX; Yang Y; Guo R; Zhou N; Liu YR; Zheng GP
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11553-11560. PubMed ID: 33275221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel NAA10 p.(R83H) variant with impaired acetyltransferase activity identified in two boys with ID and microcephaly.
    Ree R; Geithus AS; Tørring PM; Sørensen KP; Damkjær M; ; Lynch SA; Arnesen T
    BMC Med Genet; 2019 Jun; 20(1):101. PubMed ID: 31174490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating possible maternal effect lethality and genetic background effects in Naa10 knockout mice.
    Lyon GJ; Longo J; Garcia A; Inusa F; Marchi E; Shi D; Dörfel M; Arnesen T; Aldabe R; Lyons S; Nashat MA; Bolton D
    PLoS One; 2024; 19(5):e0301328. PubMed ID: 38713657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel NAA10 variant with impaired acetyltransferase activity causes developmental delay, intellectual disability, and hypertrophic cardiomyopathy.
    Støve SI; Blenski M; Stray-Pedersen A; Wierenga KJ; Jhangiani SN; Akdemir ZC; Crawford D; McTiernan N; Myklebust LM; Purcarin G; McNall-Knapp R; Wadley A; Belmont JW; Kim JJ; Lupski JR; Arnesen T
    Eur J Hum Genet; 2018 Sep; 26(9):1294-1305. PubMed ID: 29748569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NAA10-related syndrome.
    Wu Y; Lyon GJ
    Exp Mol Med; 2018 Jul; 50(7):1-10. PubMed ID: 30054457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical analysis of novel NAA10 variants suggests distinct pathogenic mechanisms involving impaired protein N-terminal acetylation.
    McTiernan N; Tranebjærg L; Bjørheim AS; Hogue JS; Wilson WG; Schmidt B; Boerrigter MM; Nybo ML; Smeland MF; Tümer Z; Arnesen T
    Hum Genet; 2022 Aug; 141(8):1355-1369. PubMed ID: 35039925
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    McTiernan N; Darbakk C; Ree R; Arnesen T
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The N-terminal acetyltransferase Naa10 is essential for zebrafish development.
    Ree R; Myklebust LM; Thiel P; Foyn H; Fladmark KE; Arnesen T
    Biosci Rep; 2015 Aug; 35(5):. PubMed ID: 26251455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA interference screen identifies NAA10 as a regulator of PXR transcription.
    Oladimeji PO; Wright WC; Wu J; Chen T
    Biochem Pharmacol; 2019 Feb; 160():92-109. PubMed ID: 30566892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Netrin-1 induces the anti-apoptotic and pro-survival effects of B-ALL cells through the Unc5b-MAPK axis.
    Huang L; An X; Zhu Y; Zhang K; Xiao L; Yao X; Zeng X; Liang S; Yu J
    Cell Commun Signal; 2022 Aug; 20(1):122. PubMed ID: 35974411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.